Prof Mohty talks to ecancertv at ICMM 2016 about maintenance therapy in young myeloma patients after undergoing autologous stem cell transplant.

He explains how it is beneficial but that information is still lacking regarding which patients will respond most favourably.

He also tells us about the treatment of old but fit patients.

Understanding more about combinations and sequences will be key, he says.

ecancer's filming at ICMM 2016 has been kindly supported by Amgen through the ECMS Foundation. ecancer is editorially independent and there is no influence over content